National Taiwan University Hospital

Taipei, Taiwan 80756

3 studies enrolling now · 6 studies all time

What they study most

Carcinoma, Ovarian Epithelial, Cervical Intraepithelial Neoplasia Grade 2/3, Fallopian Tube Adenocarcinoma, Fallopian Tube Neoplasms, Fallopian Tube Serous Adenocarcinoma, Human Papilloma Virus Infection Type 16, Intrahepatic Cholangiocarcinoma, Malignant Tumors, NSCLC, NSCLC (Advanced Non-small Cell Lung Cancer), NSCLC (Non-small Cell Lung Cancer), NSCLC (Non-small Cell Lung Carcinoma)

Studies at this site

• Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301) — Recruiting now
• PVX4 for the Treatment of Human Papilloma Virus (HPV)16+ Cervical Dysplasia — Recruiting now
• Long Term Follow-up Study of AAVAnc80-hOTOF Gene Therapy — Enrolling by invitation
• Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery — Running, not enrolling
• A Study to Evaluate KIN-3248 in Participants With Advanced Tumors Harboring FGFR2 and//or FGFR3 Gene Alterations — Stopped early
• An Exploratory Study of Gemcitabine Hydrochloride Oral Formulation (D07001-F4) in Subjects With Malignant Tumors — Completed